Don't miss

Replay


LATEST SHOWS

IN THE PAPERS

"Mister Disloyal": Did Valls just destroy the Socialist party?

Read more

EYE ON AFRICA

South Africa: Kathrada's funeral highlights divisions within ruling ANC party

Read more

MEDIAWATCH

It's not EU, it's me

Read more

BUSINESS DAILY

Markets muted as UK begins Brexit proceedings

Read more

THE DEBATE

'Thank you and goodbye': Clock starts on Brexit negotiations (part 1)

Read more

THE DEBATE

'Thank you and goodbye': Clock starts on Brexit negotiations (part 2)

Read more

ENCORE!

Film show: 'Ghost in the Shell', 'The Confession' and Jean Rouch centenary

Read more

FOCUS

Italy: Anti-establishment mayor of Rome faces grim reality of power

Read more

MIDDLE EAST MATTERS

Refugees of rap: Using music to speak out about the Syrian war

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)